Clinical Scenario:
A 5-week-old exclusively breastfed male infant is referred for evaluation of persistent jaundice. He was born at term following an uncomplicated pregnancy and has been gaining weight appropriately. His mother reports that his stools have become progressively pale over the past 2 weeks, and his urine persistently stains the diaper yellow. On examination, he is deeply jaundiced with mild hepatomegaly. Laboratory investigations show:
- Total bilirubin: 12.4 mg/dL (212 μmol/L)
- Direct (conjugated) bilirubin: 5.8 mg/dL (99 μmol/L)
- ALT: Mildly elevated
- GGT: Elevated
Which of the following is the most appropriate next step in management?
A. Arrange an urgent hepatobiliary evaluation for suspected biliary atresia
B. Continue exclusive breastfeeding and review after 4 weeks
C. Exchange transfusion to prevent bilirubin encephalopathy
D. Reassure the parents that breast milk jaundice commonly persists beyond 1 month
E. Start phototherapy immediately
Correct Answer & Explanation:
Correct Answer
A. Arrange an urgent hepatobiliary evaluation for suspected biliary atresia
Explanation: Biliary atresia
This infant has conjugated (direct) hyperbilirubinemia, evidenced by a direct bilirubin >20% of the total bilirubin. Conjugated jaundice is always pathological and requires urgent evaluation.
The combination of:
- Persistent jaundice beyond 2 weeks
- Pale (acholic) stools
- Dark urine
- Hepatomegaly
- Elevated GGT
is highly suggestive of biliary atresia, the most common surgically correctable cause of neonatal cholestasis.
Early diagnosis is crucial because Kasai portoenterostomy has the best outcomes when performed before approximately 60 days of age, with declining success thereafter.
Why the other options are incorrect
B. Continue exclusive breastfeeding and review after 4 weeks
- Appropriate only for unconjugated breast milk jaundice after excluding pathological causes.
- Pale stools and conjugated hyperbilirubinemia exclude breast milk jaundice.
C. Exchange transfusion to prevent bilirubin encephalopathy
- Exchange transfusion is indicated for severe unconjugated hyperbilirubinemia.
- Conjugated bilirubin does not cause kernicterus.
D. Reassure the parents that breast milk jaundice commonly persists beyond 1 month
- Breast milk jaundice causes unconjugated hyperbilirubinemia with normal-colored stools and urine.
E. Start phototherapy immediately
- Phototherapy is ineffective for conjugated hyperbilirubinemia and is not indicated.
MRCPCH High-Yield Pearls
- Any infant jaundiced beyond 14 days (term) or 21 days (preterm) should have fractionated bilirubin measured.
- Conjugated hyperbilirubinemia = neonatal cholestasis until proven otherwise.
- Pale stools + dark urine + conjugated jaundice = biliary atresia until proven otherwise.
- Do not delay referral for hepatobiliary assessment; early surgery significantly improves outcomes.
Find high yield pediatric board review MCQs for post graduates exams.
External Resources
1. NASPGHAN/ESPGHAN Guideline: Evaluation of Cholestatic Jaundice in Infants – Evidence-based recommendations for evaluating conjugated hyperbilirubinemia and identifying biliary atresia in infants.
2. American Academy of Pediatrics: Guidance for the Primary Care Provider in Identifying Infants With Biliary Atresia by 2–4 Weeks of Life – Highlights early recognition, stool-colour assessment, bilirubin testing, and timely referral.
3. NICE Guideline: Jaundice in Newborn Babies Under 28 Days – Guidance on assessing prolonged jaundice and recognizing pale stools or dark urine as warning signs of liver disease.
References
- Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of NASPGHAN and ESPGHAN. J Pediatr Gastroenterol Nutr. 2017;64(1):154–168. doi: 10.1097/MPG.0000000000001334.
- Harpavat S, Garcia-Prats JA, Anaya C, Brandt ML, Finegold MJ, Haber BA, et al. Guidance for the primary care provider in identifying infants with biliary atresia by 2–4 weeks of life. Pediatrics. 2023;151(3):e2022060053. doi: 10.1542/peds.2022-060053.
- National Institute for Health and Care Excellence (NICE). Jaundice in newborn babies under 28 days. NICE guideline CG98. Available from: https://www.nice.org.uk/guidance/cg98
